ETF Holdings Breakdown of EOLS

Stock Name	Evolus Inc
Ticker	EOLS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US30052C1071
LEI	549300VYQRYBQOT8V419

EOLS institutional holdings

The adjusted close for EOLS on 2025-11-12 was 7.30

The following institutional investment holdings of EOLS have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 48,105 USD 351,167 4.2% 7.30

2025-11-12 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 13,169 -0.3% USD 96,134 3.9% 7.30

2025-11-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 45,157 USD 329,646 7.30

2025-11-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 45,157 0.3% USD 329,646 4.5% 7.30

Total = 151,588 USD 1,106,593
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-12	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	48,105	USD 351,167 4.2%	7.30
2025-11-12	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	13,169 -0.3%	USD 96,134 3.9%	7.30
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	45,157	USD 329,646	7.30
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	45,157 0.3%	USD 329,646 4.5%	7.30
Total =	151,588	USD 1,106,593

News associated with EOLS

BTIG Research Reiterates Buy Rating for Evolus (NASDAQ:EOLS): Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at BTIG Research in a research note issued to investors on Monday,Benzinga reports. They currently have a $18.00 target price on the stock. BTIG Research’s price objective would indicate a potential upside of 143.57% from the company’s current price. […] - 2025-09-10 02:40:50
Evolus (NASDAQ:EOLS) Cut to “Sell” at Wall Street Zen: Wall Street Zen lowered shares of Evolus (NASDAQ:EOLS – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. A number of other brokerages have also recently issued reports on EOLS. HC Wainwright reduced their price objective on Evolus from $27.00 to $20.00 and set a “buy” […] - 2025-08-12 03:11:00
Evolus (NASDAQ:EOLS) Hits New 1-Year Low Following Analyst Downgrade: Shares of Evolus, Inc. (NASDAQ:EOLS – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research lowered their price target on the stock from $21.00 to $18.00. BTIG Research currently has a buy rating on the stock. Evolus traded as low as $5.85 and last traded at $6.37, with […] - 2025-08-07 02:24:59
Y Intercept Hong Kong Ltd Invests $449,000 in Evolus, Inc. (NASDAQ:EOLS): Y Intercept Hong Kong Ltd purchased a new position in Evolus, Inc. (NASDAQ:EOLS – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor purchased 37,361 shares of the company’s stock, valued at approximately $449,000. Other large investors have also recently made changes to their positions in the company. KLP Kapitalforvaltning AS bought a […] - 2025-07-29 05:16:59
Evolus (NASDAQ:EOLS) Shares Down 5.5% on Insider Selling: Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares dropped 5.5% on Tuesday following insider selling activity. The company traded as low as $9.31 and last traded at $9.42. Approximately 110,433 shares traded hands during trading, a decline of 88% from the average daily volume of 938,410 shares. The stock had previously closed at $9.96. Specifically, […] - 2025-06-18 02:10:53
Evolus (NASDAQ:EOLS) Shares Gap Up After Insider Buying Activity: Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $9.87, but opened at $10.17. Evolus shares last traded at $10.38, with a volume of 256,876 shares. Specifically, Director Albert G. White III bought 20,000 shares of the company’s […] - 2025-06-12 02:15:00
Man Group plc Purchases Shares of 10,931 Evolus, Inc. (NASDAQ:EOLS): Man Group plc purchased a new stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 10,931 shares of the company’s stock, valued at approximately $121,000. A number of other hedge funds also recently bought and sold shares […] - 2025-05-29 05:40:57
Nuveen Asset Management LLC Has $8.50 Million Stock Position in Evolus, Inc. (NASDAQ:EOLS): Nuveen Asset Management LLC lowered its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 14.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 769,576 shares of the company’s stock after selling 127,530 shares during the quarter. Nuveen Asset Management LLC’s holdings in Evolus were worth $8,496,000 as of its most […] - 2025-05-29 04:56:56
BNP Paribas Financial Markets Has $400,000 Position in Evolus, Inc. (NASDAQ:EOLS): BNP Paribas Financial Markets cut its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 42.3% during the 4th quarter, Holdings Channel reports. The fund owned 36,213 shares of the company’s stock after selling 26,535 shares during the period. BNP Paribas Financial Markets’ holdings in Evolus were worth $400,000 as of its most […] - 2025-05-26 04:24:47
Price T Rowe Associates Inc. MD Buys 6,332 Shares of Evolus, Inc. (NASDAQ:EOLS): Price T Rowe Associates Inc. MD increased its stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 13.7% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 52,593 shares of the company’s stock after acquiring an additional 6,332 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Evolus were worth […] - 2025-05-13 04:32:48
Schonfeld Strategic Advisors LLC Increases Position in Evolus, Inc. (NASDAQ:EOLS): Schonfeld Strategic Advisors LLC lifted its position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 62.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 34,700 shares of the company’s stock after buying an additional 13,363 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in […] - 2025-05-12 05:42:54
Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Invesco Ltd.: Invesco Ltd. reduced its position in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 81.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,326 shares of the company’s stock after selling 83,072 shares during the quarter. Invesco Ltd.’s holdings in Evolus were worth $202,000 at the end of the most recent quarter. Other institutional investors […] - 2025-05-05 04:26:46
ExodusPoint Capital Management LP Purchases New Position in Evolus, Inc. (NASDAQ:EOLS): ExodusPoint Capital Management LP acquired a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, Holdings Channel reports. The fund acquired 13,525 shares of the company’s stock, valued at approximately $149,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes […] - 2025-04-15 04:38:57
KLP Kapitalforvaltning AS Invests $106,000 in Evolus, Inc. (NASDAQ:EOLS): KLP Kapitalforvaltning AS bought a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 9,600 shares of the company’s stock, valued at approximately $106,000. Several other large investors have also recently added to or reduced their […] - 2025-04-11 05:14:55
Evolus, Inc. (NASDAQ:EOLS) Position Boosted by Intech Investment Management LLC: Intech Investment Management LLC raised its holdings in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 32.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,674 shares of the company’s stock after acquiring an additional 4,613 shares during the period. […] - 2025-03-27 06:29:02
HC Wainwright Reaffirms “Buy” Rating for Evolus (NASDAQ:EOLS): Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 100.00% from the stock’s current price. Several […] - 2025-03-07 04:50:44
China Universal Asset Management Co. Ltd. Acquires 1,291 Shares of Evolus, Inc. (NASDAQ:EOLS): China Universal Asset Management Co. Ltd. grew its holdings in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 10.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 13,426 shares of the company’s stock after acquiring an additional 1,291 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Evolus were worth $148,000 […] - 2025-02-04 06:53:02

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.